Transplant Immunology, Journal Year: 2024, Volume and Issue: 88, P. 102151 - 102151
Published: Nov. 20, 2024
Language: Английский
Transplant Immunology, Journal Year: 2024, Volume and Issue: 88, P. 102151 - 102151
Published: Nov. 20, 2024
Language: Английский
Pediatric Transplantation, Journal Year: 2025, Volume and Issue: 29(4)
Published: May 7, 2025
ABSTRACT Introduction Pediatric Infectious Disease (PID) clinicians involved in solid organ transplantation often assess infection risk and mitigation strategies for donor offers. While some guidance is available, real‐life practice patterns have not been previously described. Methods We surveyed PID about acceptance associated posttransplantation interventions using 12 fictitious pediatric case scenarios through 3 PID‐specific listservs. Descriptive statistics were employed. Results 48 (71.6%) of 67 ID respondents offer assessment. Agreement was strong (> 80%) to accept (syphilis, severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2], MRSA, E. coli , TB [liver], rhino/enterovirus) or decline (undifferentiated encephalitis, [lung]) organs from these cases, while there less agreement cases with coccidioidomycosis, Chagas disease, multi‐drug‐resistant Acinetobacter baumannii influenza. Less present posttransplant monitoring antimicrobial administration. Practice varied testing treatment donors SARS‐CoV‐2 positive test, MRSA bacteremia, disease. Conclusions For many scenarios, high; however, improved education based on currently available recommendations may enhance decision‐making. The variability management highlights educational research opportunities optimize limit the impact donor‐derived infections recipients.
Language: Английский
Citations
0Transplant Immunology, Journal Year: 2024, Volume and Issue: 88, P. 102151 - 102151
Published: Nov. 20, 2024
Language: Английский
Citations
0